Drug Safety
Meral K. El Ramahi, MD MeralElRamahiMD
4 years 11 months ago
Retrosp study in France compared MRIs of 96 pts w/ SpA (65% w/ IBP) vs 104 w/o (25% w/ IBP):
- 65% of pts w/ SpA had bone marrow edema (BME) mainly in the iliac quad of intermed middle segment
- 20% w/o SpA had BME mainly in antero-middle quad. #Abst1535 #ACR2020 @RheumNow https://t.co/1ptGGUbUS4
sheila RHEUMarampa
4 years 11 months ago
How often do you perform NFC in suspected SSc patients? @RheumNow #ACR20
Axial Spondyloarthritis Agents: Dr Antoni Chan
Dr. Chan reviews several abstracts #1366, #1367 and #1364 at the 2020 ACR annual meeting.
Hesitancy around Steroids and Vaccines: Dr. Kevin Winthrop
OHSU's Dr. Kevin Winthrop discusses two issues -- steroids and vaccines -- by looking at abstracts #1014, #0632, #0634 and #1135 at ACR 2020.
A New Pathway in Psoriatic Arthritis: Dr. Eric Ruderman
Dr. Ruderman discusses a new pathway - the use of deucravacitinib - for the treatment of psoriatic arthritis (abstracts L03) at the ACR 2020 annual meeting.
Citrulline Reactive B Cells Present in Lungs of Risk, Early RA: Richard Conway
Dr. Conway discusses ACR abstract #1445 presented Sunday at the ACR annual meeting.
Check on Pneumococcal Vaccination: Dr. Janet Pope
Dr. Janet Pope reviews abstracts #0456 and #0457 presented at the 2020 ACR annual meeting.
Improving Response to Pegloticase: Dr. Nicola Dalbeth
Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952.
Warfarin and Risk of Hip and Knee Replacements: Dr. Mrinalini Dey
Dr. Mrinalini Dey reviews abstract #0934 presented Saturday at the 2020 ACR annual meeting.
Meral K. El Ramahi, MD MeralElRamahiMD
4 years 11 months ago
Pleiotropic effect of IL6, interesting points to note:
— it can cause pain
— it can cause fatigue (IL6 impacts hepcidin w/ subsequent development of iron deficiency)
— IL6 levels increase in those w/ poor sleep
#ACR20 @RheumNow @CCalabreseDO
Warfarin and End-Stage Osteoarthritis: Dr. David Liew
Dr. David Liew discusses abstract #0934 presented at the 2020 ACR annual meeting.
sheila RHEUMarampa
4 years 11 months ago
Older patients with polypharmacy are at ⬆ risk for drug-drug reactions and adverse effects. @RheumNow #ACR20 https://t.co/uKsYO9B8PZ
Eric Dein ejdein1
4 years 11 months ago
Dr. Subedi: "we need to stop blaming just the age" in geriatric patients for adherence. Busy, middle aged patients more likely than geriatrics to have adherence issues. 3S040. Pharmaco Pearls for Older Rheum Pt. #ACR20 @RheumNow https://t.co/3UAkjRNT3u
Dr. John Cush RheumNow
4 years 11 months ago
The RheumNow podcast on #ACR20 Day 1 Part II is now available for download. Follow the link below to listen in or find us on Apple.
https://t.co/W6EMQiF9Rf https://t.co/ZlFDiVgAKl
Sole RetamozoSole
4 years 11 months ago
Withdrawal of MMF may be safely in #SLE patients in remission #ACR20 @RheumNow Dr Chakravarty https://t.co/xnpagKNu96
Poster Hall